At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 273 enrolled
Drug / intervention
Ortho Tri-cyclen Lo +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Acceptability of the NuvaRing Among College and Graduate Students
In Brief
A Phase 4 clinical trial evaluating Ortho Tri-cyclen Lo and NuvaRing for Birth Control Compliance. Completed, enrolled 273 participants across 3 sites.
Detailed Summary
The ACCEPT study is a Phase IV trial in which women are randomized to either the NuvaRing® vaginal contraceptive ring or a low dose oral contraceptive to assess compliance, side effects, overall acceptability and intent to continue use of the method. The study is focused on the acceptability of the vaginal ring among female undergraduate or graduate students.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBirth Control Compliance
CountriesUnited States
CollaboratorsOrganon
Timeline
Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMar 2008
Enrollment StartJul 2008
Primary CompletionJan 2009
Study CompletionJul 2009
TodayJul 2026
First PostedMar 13, 2008
Enrollment StartJul 1, 2008
Primary CompletionJan 1, 2009
Study CompletionJul 1, 2009
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 18.3 years ago
Interventions
Ortho Tri-cyclen Lodrug
Low dose oral contraceptive
NuvaRingdevice
Contraceptive vaginal ring